Michael Korn as its Chief Medical and Scientific Officer effective 12 August 2024. Before joining Biocartis, Dr. Korn served ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Biocartis welcomes Dr. W. Michael Korn as Chief Medical and Scientific Officer, leveraging his oncology expertise to enhance molecular testing for cancer. As a child, EJ Beck was treated for a ...